Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-13

Clinical Trial Update: The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation [Phase 4]

View source ↗

Summary

This update notes the completion of the Phase 4 Contact PVI trial evaluating tissue-contact data to guide atrial fibrillation ablation. The study is sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED